Answers are grounded in this paper and cite their sources.
Novel nanotherapeutic SHED-exosomes activate mitophagy in senescent BMSCs, improving bone health.
SHED-Exo ameliorate age-related OP by activating mitophagy in senescent BMSCs, serving as a novel translational nanotherapeutic for age-related bone disorders.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: